NM_014844.5:c.952-5G>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_014844.5(TECPR2):c.952-5G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.039 ( 0 hom., cov: 0)
Exomes 𝑓: 0.13 ( 22 hom. )
Failed GnomAD Quality Control
Consequence
TECPR2
NM_014844.5 splice_region, intron
NM_014844.5 splice_region, intron
Scores
2
Splicing: ADA: 0.00004718
2
Clinical Significance
Conservation
PhyloP100: -0.377
Publications
0 publications found
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
TECPR2 Gene-Disease associations (from GenCC):
- hereditary spastic paraplegia 49Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 14-102428245-G-T is Benign according to our data. Variant chr14-102428245-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 702193.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TECPR2 | NM_014844.5 | c.952-5G>T | splice_region_variant, intron_variant | Intron 6 of 19 | ENST00000359520.12 | NP_055659.2 | ||
| TECPR2 | NM_001172631.3 | c.952-5G>T | splice_region_variant, intron_variant | Intron 6 of 16 | NP_001166102.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TECPR2 | ENST00000359520.12 | c.952-5G>T | splice_region_variant, intron_variant | Intron 6 of 19 | 1 | NM_014844.5 | ENSP00000352510.7 | |||
| TECPR2 | ENST00000558678.1 | c.952-5G>T | splice_region_variant, intron_variant | Intron 6 of 16 | 1 | ENSP00000453671.1 |
Frequencies
GnomAD3 genomes AF: 0.0393 AC: 1020AN: 25938Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
1020
AN:
25938
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00449 AC: 98AN: 21844 AF XY: 0.00434 show subpopulations
GnomAD2 exomes
AF:
AC:
98
AN:
21844
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.132 AC: 62206AN: 472908Hom.: 22 Cov.: 17 AF XY: 0.128 AC XY: 29602AN XY: 231568 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
62206
AN:
472908
Hom.:
Cov.:
17
AF XY:
AC XY:
29602
AN XY:
231568
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1088
AN:
10422
American (AMR)
AF:
AC:
154
AN:
6802
Ashkenazi Jewish (ASJ)
AF:
AC:
465
AN:
8822
East Asian (EAS)
AF:
AC:
228
AN:
18366
South Asian (SAS)
AF:
AC:
1961
AN:
13046
European-Finnish (FIN)
AF:
AC:
217
AN:
21768
Middle Eastern (MID)
AF:
AC:
144
AN:
1698
European-Non Finnish (NFE)
AF:
AC:
55831
AN:
370522
Other (OTH)
AF:
AC:
2118
AN:
21462
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.281
Heterozygous variant carriers
0
5743
11487
17230
22974
28717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2874
5748
8622
11496
14370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0393 AC: 1020AN: 25954Hom.: 0 Cov.: 0 AF XY: 0.0359 AC XY: 449AN XY: 12498 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1020
AN:
25954
Hom.:
Cov.:
0
AF XY:
AC XY:
449
AN XY:
12498
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
272
AN:
7040
American (AMR)
AF:
AC:
68
AN:
2320
Ashkenazi Jewish (ASJ)
AF:
AC:
20
AN:
638
East Asian (EAS)
AF:
AC:
24
AN:
1106
South Asian (SAS)
AF:
AC:
47
AN:
906
European-Finnish (FIN)
AF:
AC:
14
AN:
1034
Middle Eastern (MID)
AF:
AC:
0
AN:
28
European-Non Finnish (NFE)
AF:
AC:
559
AN:
12340
Other (OTH)
AF:
AC:
12
AN:
376
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.350
Heterozygous variant carriers
0
45
90
136
181
226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Hereditary spastic paraplegia 49 Benign:1
Feb 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.